SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001395064-22-000016
Filing Date
2022-01-14
Accepted
2022-01-14 06:06:34
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 13G/A sc13ga-2_011422.htm SC 13G/A 68180
2 EX-99.1 exhibit991-2_011422.htm EX-99.1 1936
3 EX-99.2 exhibit992-2_011422.htm EX-99.2 7321
4 EX-99.3 exhibit993-2_011422.htm EX-99.3 9953
  Complete submission text file 0001395064-22-000016.txt   88864
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Subject) CIK: 0001680367 (see all company filings)

IRS No.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91760 | Film No.: 22530385
SIC: 2834 Pharmaceutical Preparations